MARY MACCARTHY: Open Payments
NPI 1689299513 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$215 in 10 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $34 · 2025 $215
Food & beverage: $215
| Company | Payments | Amount |
|---|---|---|
| BeOne Medicines USA, Inc. | 1 | $34 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| PharmaEssentia USA Corporation | 1 | $26 |
| Incyte Corporation | 1 | $22 |
| ABBVIE INC. | 1 | $21 |
| Pharmacosmos Therapeutics Inc. | 1 | $21 |
| TerSera Therapeutics LLC | 1 | $18 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $18 |
| Janssen Biotech, Inc. | 1 | $15 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $11 |
Products named: BRUKINSA, Fabhalta, BESREMI, ZYNYZ, VENCLEXTA, MONOFERRIC, Xermelo, ZYNLONTA.
Industry payments across DC — which companies pay providers there.
